$-0.48
(Market cap
$815 Mln
Revenue (TTM)
$186 Mln
P/E Ratio
--
P/B Ratio
1.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
34.03
-
EV/EBITDA
-13
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.7
-
Face value
--
-
Shares outstanding
50,649,100
10 Years Aggregate
CFO
$-33.76 Mln
EBITDA
$-176.27 Mln
Net Profit
$-510.89 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CryoPort (CYRX)
| 67.6 | 6.2 | 14.8 | 83.5 | 4.4 | -23.3 | 23.2 |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
CryoPort (CYRX)
| 23.4 | -49.5 | -10.7 | -70.7 | 34.8 | 166.6 | 49.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
CryoPort (CYRX)
|
16.1 | 814.9 | 186.5 | -36.3 | -15.5 | -7.3 | -- | 1.9 |
| 136.5 | 3,051.9 | 4,204.1 | 16.3 | 0.8 | 1.3 | 195.1 | 2.5 | |
| 47.6 | 5,203.2 | 13,641.0 | 131.0 | 2.3 | 4.3 | 40.9 | 1.8 | |
| 67.2 | 11,296.9 | 7,729.3 | 42.9 | 2.9 | 0.6 | 257.1 | 1.6 | |
| 180.0 | 6,109.7 | 4,983.4 | 131.7 | 4.0 | 16.1 | 46.8 | 7.4 | |
| 21.9 | 3,717.4 | 6,089.0 | -105.0 | -2.1 | -6.9 | -- | 2.4 | |
| 245.9 | 9,504.3 | 12,846.0 | 496.0 | 6.1 | 16.7 | 20.2 | 3.3 | |
| 352.3 | 9,371.7 | 3,392.3 | 278.0 | 11.2 | 10.5 | 34 | 3.4 | |
| 34.4 | 6,160.1 | 5,819.2 | 111.6 | 3.1 | 3.7 | 54.9 | 2.0 | |
| 21.5 | 16,249.0 | 53,904.3 | 10,260.3 | 10.9 | 15.6 | 12.7 | 1.8 |
Shareholding Pattern
View DetailsAbout CryoPort (CYRX)
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and... biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee. Read more
-
Chairman, President & CEO
Mr. Jerrell W. Shelton
-
Chairman, President & CEO
Mr. Jerrell W. Shelton
-
Headquarters
Brentwood, TN
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for CryoPort (CYRX)
What is the current share price of CryoPort Inc (CYRX) Today?
The share price of CryoPort Inc (CYRX) is $16.09 (NASDAQ) as of 28-Aug-2026 16:00 EDT. CryoPort Inc (CYRX) has given a return of 4.4% in the last 3 years.
What is the current PB & PE ratio of CryoPort Inc (CYRX)?
Since, TTM earnings of CryoPort Inc (CYRX) is negative, P/E ratio is not available.
The P/B ratio of CryoPort Inc (CYRX) is 1.89 times as on 28-Aug-2026, a 45 discount to its peers’ median range of 3.45 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
6.10 |
0.95 |
2024 |
-3.88 |
0.96 |
2023 |
-20.32 |
1.55 |
2022 |
-3.05 |
1.51 |
2021 |
-10.31 |
4.43 |
What is the 52 Week High and Low of CryoPort Inc (CYRX)?
The 52-week high and low of CryoPort Inc (CYRX) are Rs 17.20 and Rs 7.61 as of 31-Aug-2026.
What is the market cap of CryoPort Inc (CYRX)?
CryoPort Inc (CYRX) has a market capitalisation of $ 815 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in CryoPort Inc (CYRX)?
Before investing in CryoPort Inc (CYRX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.